Literature DB >> 3923951

Reduction of peripheral blood lymphocytes in patients receiving gold therapy for rheumatoid arthritis.

J G Hanly, B Bresnihan.   

Abstract

Peripheral blood lymphocytes were monitored prospectively in 10 patients with rheumatoid arthritis (RA) receiving up to 1 g of sodium aurothiomalate. There was a significant fall in the absolute lymphocyte count from a mean +/- SEM of 1956 +/- 190/mm3 (1.956 +/- 0.19 X 10(9)/l) to 1232 +/- 210/mm3 (1.232 +/- 0.21 X 10(9)/l) (p less than 0.01). The number of of circulating lymphocytes fell in all patients by an amount which ranged between 108/mm3 (0.108 X 10(9)/l) and 1394/mm3 (1.394 X 10(9)/l), with a mean fall of 727/mm3 (0.727 X 10(9)/l). No significant change was noted in the total white cell count or total polymorphonuclear cell count over the same period. In contrast there was no change in the total lymphocyte count in an age and sex matched group of RA patients treated with penicillamine. This previously unreported observation may give new insight into the mechanism of action of gold salts in RA.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3923951      PMCID: PMC1001635          DOI: 10.1136/ard.44.5.299

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  9 in total

1.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

2.  Lymphocyte involvement in rheumatoid arthritis. Studies during thoracic duct drainage.

Authors:  H E Paulus; H I Machleder; S Levine; D T Yu; N S MacDonald
Journal:  Arthritis Rheum       Date:  1977 Jul-Aug

3.  Evaluation of T cell subsets with monoclonal antibodies in patients with rheumatoid arthritis.

Authors:  E M Veys; P Hermanns; J Schindler; P C Kung; G Goldstein; J Symoens; J Van Wauwe
Journal:  J Rheumatol       Date:  1982 Jan-Feb       Impact factor: 4.666

4.  Inhibition by gold of human lymphocyte stimulation. An in vitro study.

Authors:  R B Lies; C Cardin; H E Paulus
Journal:  Ann Rheum Dis       Date:  1977-06       Impact factor: 19.103

5.  Lymphapheresis in rheumatoid arthritis. A randomized trial.

Authors:  J Karsh; J H Klippel; P H Plotz; J L Decker; D G Wright; M W Flye
Journal:  Arthritis Rheum       Date:  1981-07

6.  Enhanced T helper cell function for the spontaneous production of IgM rheumatoid factor in vitro in rheumatoid arthritis.

Authors:  V Patel; G S Panayi
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

7.  Inhibition of antigen- and mitogen-induced human lymphocyte proliferation by gold compounds.

Authors:  P E Lipsky; M Ziff
Journal:  J Clin Invest       Date:  1977-03       Impact factor: 14.808

8.  Analysis of T cell subsets in the peripheral blood and synovial fluid of patients with rheumatoid arthritis by means of monoclonal antibodies.

Authors:  O Duke; G S Panayi; G Janossy; L W Poulter; N Tidman
Journal:  Ann Rheum Dis       Date:  1983-08       Impact factor: 19.103

9.  The assessment of disease activity in rheumatoid arthritis using a multivariate analysis.

Authors:  R K Mallya; B E Mace
Journal:  Rheumatol Rehabil       Date:  1981-02-01
  9 in total
  7 in total

1.  Unique properties of auranofin as a potential anti-rheumatic drug.

Authors:  M L Barrett; G P Lewis
Journal:  Agents Actions       Date:  1986-10

2.  The immunological consequences of gold therapy: a prospective study in patients with rheumatoid arthritis.

Authors:  J Hassan; J Hanly; B Bresnihan; C Feighery; C A Whelan
Journal:  Clin Exp Immunol       Date:  1986-03       Impact factor: 4.330

3.  Failure to show a fall in peripheral blood lymphocytes in patients receiving gold or penicillamine for rheumatoid arthritis.

Authors:  M Ishigami; A J Chuck; A J Swannell; M Doherty; K Gordon
Journal:  Ann Rheum Dis       Date:  1987-03       Impact factor: 19.103

4.  Effect of sodium aurothiomalate on carrageenan induced inflammation of the air pouch in mice.

Authors:  Y M Sin; M K Wong
Journal:  Ann Rheum Dis       Date:  1992-01       Impact factor: 19.103

5.  Immunomodulatory effects of therapeutic gold compounds. Gold sodium thiomalate inhibits the activity of T cell protein kinase C.

Authors:  K Hashimoto; C E Whitehurst; T Matsubara; K Hirohata; P E Lipsky
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

6.  Effects of chrysotherapy on circulating lymphocyte numbers and subsets.

Authors:  M D Smith; A Smith; M Fehr; M J Ahern; P J Roberts-Thomson
Journal:  Ann Rheum Dis       Date:  1988-01       Impact factor: 19.103

7.  Lymphopenia in rheumatoid arthritis.

Authors:  D P Symmons; M Farr; M Salmon; P A Bacon
Journal:  J R Soc Med       Date:  1989-08       Impact factor: 18.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.